Showing results (471-480 of 2,397) with videos related to

Sort By:
Pageof 240
Translational Lung Cancer Research|August 9, 2024
PD-L1 expression from surgically resected lung tumors predictive of early progression in patients previously treated with targeted therapy for initially unresectable non-small cell lung cancerJeong Uk Lim, Hye Seon Kang, Mi Hyoung Moon, et al.
Translational Lung Cancer Research|July 8, 2024
Heterogeneity of lymphocyte subsets in predicting immune checkpoint inhibitor treatment response in advanced lung cancer: an analysis across different pathological types, therapeutic drugs, and age groupsChuanwang Miao, Yuanji Chen, Hao Zhang, et al.
Translational Lung Cancer Research|July 8, 2024
Predicting MET exon 14 skipping mutation in pulmonary sarcomatoid carcinoma by whole-tumour texture analysis combined with clinical and conventional contrast-enhanced computed tomography featuresLei Miao, Tian Qiu, Yan Li, et al.
Translational Lung Cancer Research|July 8, 2024
PSME3 promotes lung adenocarcinoma development by regulating the TGF-β/SMAD signaling pathwayShuai Wang, Yongmeng Li, Kai Jin, et al.
Translational Lung Cancer Research|July 8, 2024
Neoadjuvant aumolertinib monotherapy for EGFR-mutant lung squamous cell carcinoma: a case reportYue Liu, Xiaoxia Yan, Dongliang Bian, et al.
Translational Lung Cancer Research|July 8, 2024
Predictive value of delta-radiomic features for prognosis of advanced non-small cell lung cancer patients undergoing immune checkpoint inhibitor therapyXiaoyu Han, Yujin Wang, Xi Jia, et al.
Translational Lung Cancer Research|July 8, 2024
Prominent response to savolitinib monotherapy in high-grade fetal adenocarcinoma with MET amplification and concurrent brain metastasis: a case reportLan Shen, Jikai Zhao, Ying Yang, et al.
Translational Lung Cancer Research|June 10, 2024
Pleural carbohydrate antigen 50 and malignant pleural effusion: a prospective, double-blind diagnostic accuracy testSu-Na Cha, Yan Niu, Jian-Xun Wen, et al.
Translational Lung Cancer Research|June 10, 2024
GPRC5A is a potential prognostic biomarker and correlates with immune cell infiltration in non-small cell lung cancerYicong Lin, Yue Wang, Qianqian Xue, et al.
Translational Lung Cancer Research|April 11, 2024
A cross-trait study of lung cancer and its related respiratory diseases based on large-scale exome sequencing populationYunke Jiang, Hongru Li, Zaiming Li, et al.
Pageof 240